Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial.
Schömig A, Mehilli J, Antoniucci D, Ndrepepa G, Markwardt C, Di Pede F, Nekolla SG, Schlotterbeck K, Schühlen H, Pache J, Seyfarth M, Martinoff S, Benzer W, Schmitt C, Dirschinger J, Schwaiger M, Kastrati A; Beyond 12 hours Reperfusion AlternatiVe Evaluation (BRAVE-2) Trial Investigators. Schömig A, et al. Among authors: schuhlen h. JAMA. 2005 Jun 15;293(23):2865-72. doi: 10.1001/jama.293.23.2865. JAMA. 2005. PMID: 15956631 Clinical Trial.
Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis.
Schömig A, Ndrepepa G, Mehilli J, Schwaiger M, Schühlen H, Nekolla S, Pache J, Martinoff S, Bollwein H, Kastrati A. Schömig A, et al. Among authors: schuhlen h. Circulation. 2003 Sep 2;108(9):1084-8. doi: 10.1161/01.CIR.0000086346.32856.9C. Epub 2003 Aug 18. Circulation. 2003. PMID: 12925458 Clinical Trial.
Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR-DIRECT trial).
Mehilli J, Kastrati A, Dirschinger J, Etzel L, Bollwein H, Pache J, Schühlen H, Von Beckerath N, Seyfarth M, Schmitt C, Schömig A. Mehilli J, et al. Among authors: schuhlen h. Catheter Cardiovasc Interv. 2004 Feb;61(2):190-5. doi: 10.1002/ccd.10706. Catheter Cardiovasc Interv. 2004. PMID: 14755810 Clinical Trial.
A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy.
Kastrati A, Mehilli J, Nekolla S, Bollwein H, Martinoff S, Pache J, Schühlen H, Seyfarth M, Gawaz M, Neumann FJ, Dirschinger J, Schwaiger M, Schömig A; STOPAMI-3 Study Investigators. Kastrati A, et al. Among authors: schuhlen h. J Am Coll Cardiol. 2004 Mar 3;43(5):734-41. doi: 10.1016/j.jacc.2003.07.054. J Am Coll Cardiol. 2004. PMID: 14998609 Free article. Clinical Trial.
A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.
Pache J, Kastrati A, Mehilli J, Bollwein H, Ndrepepa G, Schühlen H, Martinoff S, Seyfarth M, Nekolla S, Dirschinger J, Schwaiger M, Schömig A. Pache J, et al. Among authors: schuhlen h. Am Heart J. 2004 Jul;148(1):e3. doi: 10.1016/j.ahj.2004.01.019. Am Heart J. 2004. PMID: 15215812 Clinical Trial.
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
Mehilli J, Kastrati A, Schühlen H, Dibra A, Dotzer F, von Beckerath N, Bollwein H, Pache J, Dirschinger J, Berger PP, Schömig A; Intracoronary Stenting and Antithrombotic Regimen: Is Abciximab a Superior Way to Eliminate Elevated Thrombotic Risk in Diabetics (ISAR-SWEET) Study Investigators. Mehilli J, et al. Among authors: schuhlen h. Circulation. 2004 Dec 14;110(24):3627-35. doi: 10.1161/01.CIR.0000148956.93631.4D. Epub 2004 Nov 7. Circulation. 2004. PMID: 15531766 Clinical Trial.
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schühlen H, Schmitt C, Dirschinger J, Schömig A; ISAR-DESIRE Study Investigators. Kastrati A, et al. Among authors: schuhlen h. JAMA. 2005 Jan 12;293(2):165-71. doi: 10.1001/jama.293.2.165. JAMA. 2005. PMID: 15644543 Clinical Trial.
79 results